Mereo BioPharma Group plc (MREO) has a market capitalization of $52.51M and trades at $0.33. The 52-week range is 0.2-3.05.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.3, Earnings Per Share (EPS) of $-0.26, annual revenue of $500K.
The stock has a beta of 0.38, operates in the Healthcare sector.
